期刊
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION
卷 13, 期 2, 页码 499-503出版社
ASIAN PACIFIC ORGANIZATION CANCER PREVENTION
DOI: 10.7314/APJCP.2012.13.2.499
关键词
Human colorectal cancer; norcantharidin; angiogenesis; vascular endothelial growth factor
类别
资金
- National Natural Science Foundation of China [81173221/H2708]
- Shanghai Committee of Science and Technology, China [10ZR1428700, 10140902600]
- Shanghai Municipal Education Commission [12YZ057, 12YZ058]
- The Shanghai 3rd Leading Academic Discipline Project [S30302]
The present study was based on the unexpected discovery that norcantharidin exerted anti-angiogenesis activity when effects on growth of human colon cancer were studied. The aim was to further verify this finding and explore possible mechanisms using a tumor xenograft model in nude mice. We confirmed that norcantharidin (5 or 15 mg/kg) could inhibit angiogenesis of human colon cancer in vivo. In vitro, crossing river assay, cell adhesion assay and tube formation assay indicated that NCTD could reduce the migration, adhesion and vascular network tube formation ability of HUVECs. At the same time, the expression levels of VEGF and VEGFR-2 proteins which play important roles in angiogenesis were reduced as examined by western blotting analysis. Taken together, the results firstly showed NCTD could inhibit angiogenesis of human colon cancer in vivo, probably associated with effects on migration, adhesion and vascular network tube formation of HUVECs and expression levels of VEGF and VEGFR-2 proteins.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据